FDA

FDA clears first treatment for dry AMD, with LumiThera’s Valeda

LumiThera’s Valeda system relies on photobiomodulation, or the use of different wavelengths of light to stimulate activity in the cells of the retina.

Conor Hale Nov 6, 2024 10:30am

FDA delays decision on Merus' first-in-class cancer drug

Nov 5, 2024 9:14am

Distalmotion grabs de novo for Dexter robot in hernia repair

Nov 1, 2024 11:00am

FDA approves Medtronic's Affera 2-in-1 afib ablation system

Oct 25, 2024 12:00pm

It's official: Michelle Tarver named director of CDRH

Oct 22, 2024 3:08pm

Sangamo slashes time to market for Fabry gene therapy

Oct 22, 2024 12:57pm